Followers | 9 |
Posts | 740 |
Boards Moderated | 0 |
Alias Born | 10/06/2010 |
Tuesday, June 24, 2014 10:35:12 PM
Looks like they(KBLB/Kim Thompson) abandoned the Trademark for it.
It was the only one that didn't have a SOU filed for it. Thought this was the case, verified today:
http://tmsearch.uspto.gov/bin/showfield?f=doc&state=4803:3y90pm.2.1
Word Mark MONSTER MOTH
Goods and Services (ABANDONED) IC 023. US 043. G & S: Thread for textile use
Standard Characters Claimed
Mark Drawing Code (4) STANDARD CHARACTER MARK
Serial Number 85144332
Filing Date October 4, 2010
Current Basis 1B
Original Filing Basis 1B
Published for Opposition March 15, 2011
Owner (APPLICANT) Kraig Biocraft Laboratories, Inc. CORPORATION WYOMING 120 North Washington Square, Suite 805 Lansing MICHIGAN 48933
Attorney of Record Kevin McJessy
Type of Mark TRADEMARK
Register PRINCIPAL
Live/Dead Indicator DEAD
Abandonment Date June 16, 2014
--All other Trademarks for KBLB's Products are still live under USPTO:
1 85144332 MONSTER MOTH TSDR DEAD
2 85144551 MONSTER SILK TSDR LIVE
3 85144366 MONSTER WORM TSDR LIVE
4 85144315 SPIDER WORM TSDR LIVE
5 85144294 SPIDER MOTH TSDR LIVE
6 85144279 SPILK TSDR LIVE
7 85144234 SPIDERPILLAR TSDR LIVE
GO KBLB.
Not big news really, just staying current with the day to day activities...
Everything I say is my own opinion and should not be taken as direct investment advice. Do your own DD and make your own decisions.
Recent KBLB News
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:31:54 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 09:30:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:43:51 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/11/2023 08:30:50 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/08/2023 04:15:15 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/01/2023 08:30:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:35:05 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM